Progress In Developing Industry Guidelines for Determination of Suitability of Single Use Products f - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Progress In Developing Industry Guidelines for Determination of Suitability of Single Use Products f

Description:

... of Mechanical Engineers, Bioprocessing Equipment. ASTM ... Hydraulic Test. Conductivity. Particle Releasing. Water Flow/Pressure Drop. TOC. Non Fiber Releasing ... – PowerPoint PPT presentation

Number of Views:43
Avg rating:3.0/5.0
Slides: 25
Provided by: mmar62
Category:

less

Transcript and Presenter's Notes

Title: Progress In Developing Industry Guidelines for Determination of Suitability of Single Use Products f


1
Progress In Developing Industry Guidelines for
Determination of Suitability of Single Use
Products for Bioprocess Manufacturing Operations
  • Thomas J. Murphy, Ph.D.
  • TC Tech Corporation

2
Overview
  • The Bio-Process Systems Alliance (BPSA)
  • BPSA Guidelines and Standards Committee
  • Current Progress with Industry Guidelines
  • Future Activities

3
Bio-Process Systems Alliance (BPSA)
  • What is the BPSA?
  • Special purpose group of the Society of the
    Plastics Industry, Inc. (SPI)
  • Manufacturers of single-use process components
    and systems within the biopharmaceutical industry

4
Single-Use System Examples
5
BPSA Primary Objectives
  • Grow the market nationally and internationally by
    facilitating adoption of single-use components
    and systems
  • Establish guidelines and standards for the use
    and disposal of single-use process components and
    systems
  • Educate customers, regulatory bodies and
    non-government organizations on the benefits of
    using single-use systems

6
BPSA Guidelines and Standards Committee
  • Objective
  • To provide guidelines/recommendations for how to
    determine the suitability of single-use products
    for bioprocess manufacturing operations

7
BPSA Guidelines and Standards Committee
  • Current Activity
  • Currently developing a matrix to evaluate
    existing standards, guidelines and specifications

8
BPSA Guidelines and Standards Committee
  • Goal
  • Establish a current baseline for documenting the
    suitability of the product as used in
    biomanufacturing

9
BPSA Guidelines and Standards Committee
  • Subgroups
  • Address unique materials of construction and
    field of use for
  • Film and containers
  • Filters
  • Tubing
  • Connectors and components

10
BPSA Guidelines and Standards Committee
  • Standards and Methods in Use Include
  • 21 CFR 177 Code of Federal Regulations
  • AAMI Association for the Advancement of Medical
    Instrumentation
  • ANSI American National Standards Institute
  • ASME BPE American Society of Mechanical
    Engineers, Bioprocessing Equipment
  • ASTM International
  • BP British Pharmacopoeia

11
BPSA Guidelines and Standards Committee
  • Standards and Methods in Use Include
  • EP European Pharmacopoeia
  • ISO International Standardization Organization
  • ISTA International Safe Transit Association
  • FTMS Federal Test Method Standard
  • JP Japanese Pharmacopoeia
  • NIH National Institutes of Health
  • USP United States Pharmacopoeia

12
BPSA Guidelines and Standards Committee
  • Initial Findings
  • Variety of guidelines and standards already in
    use
  • Test methods in the physical, chemical/biological
    and functional categories may overlap
  • More than one guideline or standard may be
    appropriate for a test method
  • Product dependent
  • Resin dependent

13
BPSA Guidelines and Standards Committee
  • Challenges
  • Develop appropriate definitions that apply to
    process or product specific tests (e.g.
    sterilization, functionality)
  • Define a model system that can be used and
    validated, while taking into account
    process-specific testing
  • Address extractables/leachables

14
BPSA Guidelines and Standards Committee
  • Film Qualification Test Methods Evaluated
    Include

15
BPSA Guidelines and Standards Committee
  • Filter Qualification Test Methods Evaluated
    Include

16
BPSA Guidelines and Standards Committee
  • Tubing Qualification Test Methods Evaluated
    Include

17
BPSA Guidelines and Standards Committee
  • Connector Qualification Test Methods Evaluated
    Include

18
BPSA Guidelines and Standards Committee
  • Leachables/Extractables
  • Proposed Definitions for BPSA Guidelines
  • Extractables
  • Substances that can be extracted from a
    bioprocess container using solvents and/or
    conditions that are expected to be more
    aggressive than the conditions of contact between
    the container system and a relevant
    pharmaceutical solution
  • Leachables
  • Substances that are present in the finished
    drug product because of the interaction with a
    bioprocess container system

19
BPSA Guidelines and Standards Committee
  • Leachables/Extractables
  • Proposed Roles and Responsibilities of Vendors
    and Suppliers
  • Suppliers of bioprocess container systems
    provide vendors of finished drug products a full
    and complete extractables assessment of their
    system
  • Vendors of the drug product supply regulators
    with a full and complete leachables assessment
    for their finished drug product
  • Vendor and suppliers attempt to correlate the
    extractables and leachables information

20
BPSA Guidelines and Standards Committee
  • Leachables/Extractables
  • Proposed Characteristics of a Full and Complete
    Extractables Assessment
  • Extraction of the system with a minimum of three
    chemically diverse extraction solvents.
  • Multiple extraction conditions (duration,
    temperature material weight to extraction
    solution volume) determined to be more aggressive
    than the typical conditions of use of the system
  • Analysis of extracts
  • Detection of the extracted substances
  • Identification of the extracted substances
  • Quantification of the extracted substances

21
BPSA Guidelines and Standards Committee
  • Leachables/Extractables
  • Proposed Characteristics of a Full and Complete
    Extractables Assessment
  • Supplier will document the identity and
    concentration of extracted substances detected in
    the extracts
  • Supplier may perform and report such studies as
    may be appropriate or necessary to establish the
    source of extracted substances
  • Drug vendor would directly use such information
    to establish the safety, efficacy, and/or
    compliance of its finished product through an
    appropriate safety assessment based upon the
    actual leachables profile

22
BPSA Guidelines and Standards Committee
  • Future Activity
  • Continue identification of commonalities,
    differences in guidelines, standards
  • Each test type
  • Each of the four component categories
  • Include definitions
  • Review differences
  • Can single guideline or standard be used?
  • Do different conditions necessitate options?
  • Define model system that can be used, validated

23
BPSA Guidelines and Standards Committee
  • We want to hear from you!
  • Talk with BPSA members here at the conference
  • Provide us with your input on guidelines and
    standards for single-use components and systems
  • Contact Donna Dempsey, Executive Director, BPSA
    for more information
  • Visit the BSPA Web site at www.bpsalliance.org

24
For more information, contact
  • Donna S. Dempsey
  • Executive Director, Bio-Process Systems Alliance
    (BPSA)
  • The Society of the Plastics Industry, Inc.
  • Washington, DC
  • (202) 974-5218
  • ddempsey_at_socplas.org
  • www.bpsalliance.org
Write a Comment
User Comments (0)
About PowerShow.com